Luo, Mengdi
He, Qing
Funding for this research was provided by:
the Chengdu Science and Technology Bureau (2017FZ0058)
the Health Department of Sichuan Province (No.17PJ474)
Article History
Received: 18 November 2021
Accepted: 23 May 2022
First Online: 30 January 2023
Declarations
:
: The establishment of MIMIC-IV was approved by the institutional review boards of the Beth Israel Deaconess Medical Center (Boston, MA) and Massachusetts Institute of Technology (Cambridge, MA), thus, this study was granted a waiver of informed consent. All methods were performed in accordance with the relevant guidelines and regulations. Besides, this study was also approved by the Ethical Committee of The Chengdu Third People's Hospital, granted a waiver of informed consent (Additional attachments have been submitted).
: Not applicable.
: None declared.